Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biosite and FivePrime announce antibody collaboration.


Biosite Incorporated (San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. , CA) and Five Prime Therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
, Inc. (San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden , CA) have entered into a collaboration for the evaluation of disease targets for potential commercialization of diagnostic and therapeutic products. Under the collaboration, FivePrime will provide Biosite access to selected functional disease targets for use in developing diagnostics. In exchange, Biosite will provide FivePrime with Omniclonal antibodies for selected targets to accelerate FivePrime's therapeutic research efforts. Biosite's proprietary antibody development process generates highly diverse libraries of Omniclonal antibodies with high affinity and low cross-reactivity.

"FivePrime's comprehensive protein discovery program is providing a wealth of valuable therapeutic and diagnostic candidates. This collaboration is a strategic win for both companies. It expands Biosite's portfolio of novel diagnostic targets and provides high quality antibodies to accelerate development of FivePrime's therapeutic pipeline," commented Gail Maderis, FivePrime's president and chief executive officer.

"Biosite's discovery efforts are focused on developing a broad and diverse portfolio of novel diagnostics for diseases that lack rapid, accurate diagnostic methods," said Gunars Valkirs, Ph.D., senior vice president Biosite Discovery. "FivePrime is a recognized industry leader in the discovery of novel targets, so we are pleased to begin this collaboration." The financial terms of the agreement were not disclosed.

FivePrime is a privately held protein therapeutics discovery and development company. Its proprietary discovery platform allows the rapid screening of the complete set of secreted proteins and their receptors in medically relevant, cell-based assays to identify new biotherapeutics. FivePrime is applying its high throughput biologics discovery system first in the areas of oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors.

on·col·o·gy
n.
, diabetes, immunology immunology, branch of medicine that studies the response of organisms to foreign substances, e.g., viruses, bacteria, and bacterial toxins (see immunity). Immunologists study the tissues and organs of the immune system (bone marrow, spleen, tonsils, thymus, lymphatic  and regenerative re·gen·er·a·tive  
adj.
1. Of, relating to, or marked by regeneration.

2. Tending to regenerate.



re·gen
 medicine.

Biosite Incorporated is a leading bio-medical company commercializing proteomics discoveries for the advancement of medical diagnosis. The company's products contribute to improvements in medical care by aiding physicians in the diagnosis of critical diseases and health conditions. Biosite's Triage triage

Division of patients for priority of care, usually into three categories: those who will not survive even with treatment; those who will survive without treatment; and those whose survival depends on treatment.
 rapid diagnostics are used in approximately 50 percent of United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  hospitals and in more than 50 international markets.

Five Prime Therapeutics, Inc.

+1-415-365-5663

www.fiveprime.com

Biosite Incorporated

+1-858-805-2820

www.biosite.com
COPYRIGHT 2006 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Geographic Code:1USA
Date:Jan 1, 2006
Words:331
Previous Article:Pharmacopeia and Biovitrum collaboration advances towards development.
Next Article:Bioheart and Cleveland Clinic sign major patent licensing agreement.
Topics:



Related Articles
Cambridge Antibody Technology and AMRAD to develop antibody therapeutics.
Biosite to engineer around XOMA patent.
MorphoSys acquires anti-cancer antibodies from ProChon.
MorphoSys issued European patent for HuCAL antibody technology.
Cambridge Antibody and Dyax amend antibody product agreement.
MorphoSys and Novartis forge therapeutic antibody alliance.
Abgenix and Genentech extend antibody technology licensing agreement.
Lilly and Biosite to collaborate on clinical trial using sepsis therapy.
OPi and Vaccinex announce license of fully human anti-IL6 antibody.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles